YFY Biotech Management Company logo

YFY Biotech Management Company

Asia, T'ai-pei, Taiwan, Taipei

Description

YFY Biotech Management Company is a biotechnology investment firm that funds related companies in Taiwan.

Investor Profile

YFY Biotech Management Company has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series D rounds (top funding stages).
  • Majority of deals are located in United States, Taiwan.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Health Care.

Stage Focus

  • Series C (50%)
  • Series D (50%)

Country Focus

  • United States (75%)
  • Taiwan (25%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Diabetes
  • Medical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does YFY Biotech Management Company frequently co-invest with?

CB
North America, California, United States, San Diego
Co-Investments: 1
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 2
JAFCO Asia
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 1
Advent International
North America, Massachusetts, United States, Boston
Co-Investments: 1
Astellas Venture Management
North America, California, United States, Menlo Park
Co-Investments: 1
Hercules Capital
North America, California, United States, San Mateo
Co-Investments: 1
Oxford Bioscience Partners
North America, Massachusetts, United States, Boston
Co-Investments: 1
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 1

What are some of recent deals done by YFY Biotech Management Company?

TaiGen Biotechnology

Taipei, T'ai-pei, Taiwan

TaiGen is a pharmaceutical company discovering, developing and commercializing drugs to treat cancers, infectious diseases and diabetics.

BiotechnologyHealth CarePharmaceutical
Series CJan 1, 2009
Amount Raised: $37,000,000
Nereus Pharmaceuticals

San Diego, California, United States

Nereus Pharmaceuticals engages in the discovery and development of therapeutics for the treatment of infectious diseases and inflammation.

BiotechnologyHealth CareMedical
Series DAug 9, 2007
Amount Raised: $45,000,000
Elixir Pharmaceuticals

Cambridge, Massachusetts, United States

Elixir Pharmaceuticals develops and commercializes pharmaceuticals for the treatment of metabolic diseases.

BiotechnologyDiabetesPharmaceutical
Series CNov 27, 2006
Amount Raised: $31,000,000
Optimer Pharmaceuticals

San Diego, California, United States

Optimer Pharmaceuticals, Inc. (Optimer) is a biopharmaceutical company focused on discovering, developing and commercializing

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series DDec 14, 2005
Amount Raised: $22,200,000